Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.27 Billion CNY | -3.01% |
| 2022 | 3.38 Billion CNY | 7.37% |
| 2021 | 3.14 Billion CNY | 1.65% |
| 2020 | 3.09 Billion CNY | -12.88% |
| 2019 | 3.55 Billion CNY | 13.74% |
| 2018 | 3.12 Billion CNY | 0.99% |
| 2017 | 3.09 Billion CNY | 3.11% |
| 2016 | 3 Billion CNY | 12.42% |
| 2015 | 2.67 Billion CNY | 18.51% |
| 2014 | 2.25 Billion CNY | 12.94% |
| 2013 | 1.99 Billion CNY | 695.26% |
| 2012 | 250.91 Million CNY | 3.23% |
| 2011 | 243.06 Million CNY | 10.06% |
| 2010 | 220.84 Million CNY | -9.51% |
| 2009 | 244.04 Million CNY | -6.81% |
| 2008 | 261.86 Million CNY | -11.09% |
| 2007 | 294.51 Million CNY | 0.28% |
| 2006 | 293.68 Million CNY | -0.31% |
| 2005 | 294.58 Million CNY | -18.44% |
| 2004 | 361.19 Million CNY | 24.47% |
| 2003 | 290.18 Million CNY | 0.23% |
| 2002 | 289.51 Million CNY | -29.21% |
| 2001 | 408.98 Million CNY | -22.85% |
| 2000 | 530.13 Million CNY | 9.04% |
| 1999 | 486.19 Million CNY | -34.96% |
| 1998 | 747.53 Million CNY | 29.73% |
| 1997 | 576.21 Million CNY | 11.15% |
| 1996 | 518.43 Million CNY | 5.99% |
| 1995 | 489.14 Million CNY | 0.7% |
| 1994 | 485.73 Million CNY | 15.48% |
| 1993 | 420.63 Million CNY | 15.25% |
| 1992 | 364.96 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.29 Billion CNY | 0.4% |
| 2024 Q2 | 3.15 Billion CNY | -4.32% |
| 2024 Q3 | 3.21 Billion CNY | 1.94% |
| 2023 Q3 | 3.21 Billion CNY | -1.59% |
| 2023 FY | 3.27 Billion CNY | -3.01% |
| 2023 Q4 | 3.27 Billion CNY | 2.1% |
| 2023 Q1 | 3.17 Billion CNY | -6.08% |
| 2023 Q2 | 3.26 Billion CNY | 2.77% |
| 2022 Q4 | 3.38 Billion CNY | 5.13% |
| 2022 Q3 | 3.21 Billion CNY | 0.33% |
| 2022 Q2 | 3.2 Billion CNY | -0.15% |
| 2022 FY | 3.38 Billion CNY | 7.37% |
| 2022 Q1 | 3.21 Billion CNY | 1.95% |
| 2021 FY | 3.14 Billion CNY | 1.65% |
| 2021 Q1 | 3.16 Billion CNY | 2.14% |
| 2021 Q2 | 3.11 Billion CNY | -1.59% |
| 2021 Q3 | 3.16 Billion CNY | 1.76% |
| 2021 Q4 | 3.14 Billion CNY | -0.62% |
| 2020 Q4 | 3.09 Billion CNY | -6.95% |
| 2020 FY | 3.09 Billion CNY | -12.88% |
| 2020 Q3 | 3.32 Billion CNY | -4.7% |
| 2020 Q2 | 3.49 Billion CNY | -3.07% |
| 2020 Q1 | 3.6 Billion CNY | 1.36% |
| 2019 FY | 3.55 Billion CNY | 13.74% |
| 2019 Q1 | 3.28 Billion CNY | 5.19% |
| 2019 Q2 | 3.43 Billion CNY | 4.35% |
| 2019 Q3 | 3.58 Billion CNY | 4.47% |
| 2019 Q4 | 3.55 Billion CNY | -0.82% |
| 2018 Q2 | 3.12 Billion CNY | -1.56% |
| 2018 Q3 | 3.16 Billion CNY | 1.19% |
| 2018 Q4 | 3.12 Billion CNY | -1.28% |
| 2018 FY | 3.12 Billion CNY | 0.99% |
| 2018 Q1 | 3.17 Billion CNY | 2.7% |
| 2017 Q1 | 3.11 Billion CNY | 3.77% |
| 2017 Q4 | 3.09 Billion CNY | -3.17% |
| 2017 Q3 | 3.19 Billion CNY | 1.69% |
| 2017 Q2 | 3.14 Billion CNY | 0.91% |
| 2017 FY | 3.09 Billion CNY | 3.11% |
| 2016 Q1 | 2.64 Billion CNY | -1.01% |
| 2016 Q2 | 2.76 Billion CNY | 4.5% |
| 2016 Q3 | 2.77 Billion CNY | 0.27% |
| 2016 Q4 | 3 Billion CNY | 8.39% |
| 2016 FY | 3 Billion CNY | 12.42% |
| 2015 FY | 2.67 Billion CNY | 18.51% |
| 2015 Q3 | 2.57 Billion CNY | -2.43% |
| 2015 Q2 | 2.64 Billion CNY | 5.01% |
| 2015 Q1 | 2.51 Billion CNY | 11.59% |
| 2015 Q4 | 2.67 Billion CNY | 3.66% |
| 2014 Q3 | 2.25 Billion CNY | 3.49% |
| 2014 Q1 | 2.13 Billion CNY | 6.89% |
| 2014 FY | 2.25 Billion CNY | 12.94% |
| 2014 Q4 | 2.25 Billion CNY | 0.13% |
| 2014 Q2 | 2.17 Billion CNY | 1.97% |
| 2013 Q3 | 2.02 Billion CNY | -7.2% |
| 2013 Q2 | 2.17 Billion CNY | 733.03% |
| 2013 Q1 | 261.6 Million CNY | 4.26% |
| 2013 Q4 | 1.99 Billion CNY | -1.33% |
| 2013 FY | 1.99 Billion CNY | 695.26% |
| 2012 FY | 250.91 Million CNY | 3.23% |
| 2012 Q4 | 250.91 Million CNY | 2.32% |
| 2012 Q3 | 245.22 Million CNY | -3.32% |
| 2012 Q2 | 253.64 Million CNY | 5.92% |
| 2012 Q1 | 239.47 Million CNY | -1.48% |
| 2011 Q3 | 248.2 Million CNY | 1.9% |
| 2011 Q2 | 243.58 Million CNY | -0.58% |
| 2011 Q1 | 245 Million CNY | 10.94% |
| 2011 FY | 243.06 Million CNY | 10.06% |
| 2011 Q4 | 243.06 Million CNY | -2.07% |
| 2010 Q1 | 245.39 Million CNY | 0.55% |
| 2010 FY | 220.84 Million CNY | -9.51% |
| 2010 Q2 | 261.18 Million CNY | 6.43% |
| 2010 Q4 | 220.84 Million CNY | -14.83% |
| 2010 Q3 | 259.29 Million CNY | -0.73% |
| 2009 FY | 244.04 Million CNY | -6.81% |
| 2009 Q3 | 267.45 Million CNY | 6.04% |
| 2009 Q1 | 259.14 Million CNY | -1.04% |
| 2009 Q4 | 244.04 Million CNY | -8.75% |
| 2009 Q2 | 252.21 Million CNY | -2.67% |
| 2008 Q3 | 289.78 Million CNY | -3.48% |
| 2008 Q4 | 261.86 Million CNY | -9.63% |
| 2008 Q1 | 292.92 Million CNY | -0.54% |
| 2008 Q2 | 300.23 Million CNY | 2.5% |
| 2008 FY | 261.86 Million CNY | -11.09% |
| 2007 Q2 | 312.99 Million CNY | 14.75% |
| 2007 Q4 | 294.51 Million CNY | 0.02% |
| 2007 FY | 294.51 Million CNY | 0.28% |
| 2007 Q1 | 272.76 Million CNY | -7.12% |
| 2007 Q3 | 294.46 Million CNY | -5.92% |
| 2006 FY | 293.68 Million CNY | -0.31% |
| 2006 Q4 | 293.68 Million CNY | -5.86% |
| 2006 Q2 | 317.34 Million CNY | 1.72% |
| 2006 Q3 | 311.94 Million CNY | -1.7% |
| 2006 Q1 | 311.98 Million CNY | 5.91% |
| 2005 Q3 | 344.7 Million CNY | 1.71% |
| 2005 FY | 294.58 Million CNY | -18.44% |
| 2005 Q4 | 294.58 Million CNY | -14.54% |
| 2005 Q2 | 338.92 Million CNY | -3.48% |
| 2005 Q1 | 351.15 Million CNY | -2.78% |
| 2004 FY | 361.19 Million CNY | 24.47% |
| 2004 Q4 | 361.19 Million CNY | 18.24% |
| 2004 Q2 | 309.85 Million CNY | -34.21% |
| 2004 Q1 | 470.97 Million CNY | 62.3% |
| 2004 Q3 | 305.48 Million CNY | -1.41% |
| 2003 Q4 | 290.18 Million CNY | -2.83% |
| 2003 Q1 | 280.74 Million CNY | -3.03% |
| 2003 Q2 | 276.79 Million CNY | -1.41% |
| 2003 FY | 290.18 Million CNY | 0.23% |
| 2003 Q3 | 298.64 Million CNY | 7.9% |
| 2002 Q4 | 289.51 Million CNY | -19.06% |
| 2002 FY | 289.51 Million CNY | -29.21% |
| 2002 Q1 | 400.6 Million CNY | -2.05% |
| 2002 Q2 | 362.53 Million CNY | -9.5% |
| 2002 Q3 | 357.69 Million CNY | -1.33% |
| 2001 Q2 | 517.84 Million CNY | 0.0% |
| 2001 FY | 408.98 Million CNY | -22.85% |
| 2001 Q4 | 408.98 Million CNY | 0.0% |
| 2000 Q4 | 530.13 Million CNY | 0.0% |
| 2000 FY | 530.13 Million CNY | 9.04% |
| 2000 Q2 | 452.04 Million CNY | 0.0% |
| 1999 Q4 | 486.19 Million CNY | 0.0% |
| 1999 Q2 | 472.42 Million CNY | 0.0% |
| 1999 FY | 486.19 Million CNY | -34.96% |
| 1998 FY | 747.53 Million CNY | 29.73% |
| 1998 Q4 | 747.53 Million CNY | 0.0% |
| 1998 Q2 | 575.28 Million CNY | 0.0% |
| 1997 Q4 | 576.21 Million CNY | 0.0% |
| 1997 FY | 576.21 Million CNY | 11.15% |
| 1997 Q2 | 525.49 Million CNY | 0.0% |
| 1996 FY | 518.43 Million CNY | 5.99% |
| 1996 Q2 | 521.06 Million CNY | 0.0% |
| 1996 Q4 | 518.43 Million CNY | 0.0% |
| 1995 Q4 | 489.14 Million CNY | 0.0% |
| 1995 FY | 489.14 Million CNY | 0.7% |
| 1995 Q2 | 481.52 Million CNY | 0.0% |
| 1994 FY | 485.73 Million CNY | 15.48% |
| 1994 Q2 | 451.35 Million CNY | 0.0% |
| 1994 Q4 | 485.73 Million CNY | 0.0% |
| 1993 Q2 | 386.38 Million CNY | 0.0% |
| 1993 FY | 420.63 Million CNY | 15.25% |
| 1993 Q4 | 420.63 Million CNY | 0.0% |
| 1992 FY | 364.96 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 43.78 Billion CNY | 92.51% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 17.08 Billion CNY | 80.801% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 11.23 Billion CNY | 70.82% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | -50.849% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 346.28 Million CNY | -846.995% |
| NanJing Pharmaceutical Company Limited | 28.5 Billion CNY | 88.497% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | -24.765% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 7.77 Billion CNY | 57.802% |